P. Beaudry, P. Cohen, J. Brandel, N. Delasnerie-laupretre, S. Richard et al., 14-3-3 Protein, Neuron-Specific Enolase, and S-100 Protein in Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease, Dementia and Geriatric Cognitive Disorders, vol.10, issue.1, pp.40-46, 1999.
DOI : 10.1159/000017095

P. Belt, I. Muileman, B. Schreuder, J. Bos-de-ruijter, A. Gielkens et al., Identification of five allelic variants of the sheep PrP gene and their association with natural scrapie, Journal of General Virology, vol.76, issue.3, pp.76509-517, 1995.
DOI : 10.1099/0022-1317-76-3-509

V. Beringue, C. Lasmezas, K. Adjou, R. Demaimay, F. Lamoury et al., Inhibiting scrapie neuroinvasion by polyene antibiotic treatment of SCID mice., Journal of General Virology, vol.80, issue.7, pp.1873-1877, 1999.
DOI : 10.1099/0022-1317-80-7-1873

D. Bolton, M. Mckinley, and S. Prusiner, Identification of a protein that purifies with the scrapie prion, Science, vol.218, issue.4579, pp.1309-1311, 1982.
DOI : 10.1126/science.6815801

D. Borchelt, M. Scott, A. Taraboulos, N. Stahl, and S. Prusiner, Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells, The Journal of Cell Biology, vol.110, issue.3, pp.743-752, 1990.
DOI : 10.1083/jcb.110.3.743

P. Bosque and S. Prusiner, Cultured Cell Sublines Highly Susceptible to Prion Infection, Journal of Virology, vol.74, issue.9, pp.4377-4386, 2000.
DOI : 10.1128/JVI.74.9.4377-4386.2000

D. Brown, A. Besinger, J. Herms, and H. Kretzschmar, Microglial expression of the prion protein, NeuroReport, vol.9, issue.7, pp.1425-1429, 1998.
DOI : 10.1097/00001756-199805110-00032

D. Brown, W. Schulz-schaeffer, B. Schmidt, and H. Kretzschmar, Prion Protein-Deficient Cells Show Altered Response to Oxidative Stress Due to Decreased SOD-1 Activity, Experimental Neurology, vol.146, issue.1, pp.104-112, 1997.
DOI : 10.1006/exnr.1997.6505

K. Brown, J. Brown, D. Ritchie, J. Sales, and J. Fraser, Fetal cell grafts provide long-term protection against scrapie induced neuronal loss, Neuroreport, vol.12, issue.1, pp.77-82, 2001.
DOI : 10.1097/00001756-200101220-00023

P. Brown, E. Rau, B. Johnson, A. Bacote, C. Gibbs et al., New studies on the heat resistance of hamster-adapted scrapie agent: Threshold survival after ashing at 600{degrees}C suggests an inorganic template of replication, Proceedings of the National Academy of Sciences, vol.97, issue.7, pp.3418-3421, 2000.
DOI : 10.1073/pnas.050566797

M. Bruce, R. Will, J. Ironside, I. Mcconnell, D. Drummond et al., Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent, Nature, vol.389, issue.6650, pp.498-501, 1997.
DOI : 10.1038/39057

H. Bueler, M. Fischer, Y. Lang, H. Bluethmann, H. Lipp et al., Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein, Nature, vol.356, issue.6370, pp.577-582, 1992.
DOI : 10.1038/356577a0

A. Buschmann, A. Biacabe, U. Ziegler, A. Bencsik, J. Madec et al., Atypical scrapie cases in Germany and France are identified by discrepant reaction patterns in BSE rapid tests, Journal of Virological Methods, vol.117, issue.1, pp.27-36, 2004.
DOI : 10.1016/j.jviromet.2003.11.017

D. Butler, M. Scott, J. Bockman, D. Borchelt, A. Taraboulos et al., Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins, J Virol, vol.62, pp.1558-1564, 1988.

B. Caughey, D. Ernst, and R. Race, Congo red inhibition of scrapie agent replication, J Virol, vol.67, pp.6270-6272, 1993.

B. Caughey and R. Race, Potent Inhibition of Scrapie-Associated PrP Accumulation by Congo Red, Journal of Neurochemistry, vol.655, issue.2, pp.768-771, 1992.
DOI : 10.1016/0092-8674(83)90168-X

B. Caughey and G. Raymond, Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells, J Virol, vol.67, pp.643-650, 1993.

W. Caughey, L. Raymond, M. Horiuchi, and B. Caughey, Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines, Proceedings of the National Academy of Sciences, vol.95, issue.21, pp.12117-12122, 1998.
DOI : 10.1073/pnas.95.21.12117

L. Cervenakova, O. Yakovleva, C. Mckenzie, S. Kolchinsky, L. Mcshane et al., Similar levels of infectivity in the blood of mice infected with human-derived vCJD and GSS strains of transmissible spongiform encephalopathy, Transfusion, vol.51, issue.11, pp.1687-1694, 2003.
DOI : 10.1073/pnas.97.18.10168

J. Chapman, J. Ben-israel, Y. Goldhammer, and A. Korczyn, The risk of developing Creutzfeldt-Jakob disease in subjects with the PRNP gene codon 200 point mutation, Neurology, vol.44, issue.9, pp.1683-1686, 1994.
DOI : 10.1212/WNL.44.9.1683

J. Chapman, P. Brown, L. Goldfarb, A. Arlazoroff, D. Gajdusek et al., Clinical heterogeneity and unusual presentations of Creutzfeldt-Jakob disease in Jewish patients with the PRNP codon 200 mutation., Journal of Neurology, Neurosurgery & Psychiatry, vol.56, issue.10, pp.1109-1112, 1993.
DOI : 10.1136/jnnp.56.10.1109

S. Chen, A. Mange, L. Dong, S. Lehmann, and M. Schachner, Prion protein as trans-interacting partner for neurons is involved in neurite outgrowth and neuronal survival, Molecular and Cellular Neuroscience, vol.22, issue.2, pp.227-233, 2003.
DOI : 10.1016/S1044-7431(02)00014-3

S. Colling and H. Wheal, Fast sodium action potentials are generated in the distal apical dendrites of rat hippocampal CA1 pyramidal cells, Neuroscience Letters, vol.172, issue.1-2, pp.73-96, 1994.
DOI : 10.1016/0304-3940(94)90665-3

J. Collinge, K. Sidle, J. Meads, J. Ironside, and A. Hill, Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD, Nature, vol.383, issue.6602, pp.685-690, 1996.
DOI : 10.1038/383685a0

S. Collins, V. Lewis, M. Brazier, A. Hill, A. Fletcher et al., Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model, Annals of Neurology, vol.95, issue.4, pp.503-506, 2002.
DOI : 10.1002/ana.10336

C. Crozet, Y. Lin, C. Mettling, C. Mourton-gilles, P. Corbeau et al., Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations, Journal of Cell Science, vol.117, issue.23, pp.5591-5597, 2004.
DOI : 10.1242/jcs.01484

URL : https://hal.archives-ouvertes.fr/inserm-00143203

J. Cuillé and P. Chelle, La maladie dite " tremblante du mouton " est-elle inoculable?, C R Acad Sci, vol.203, pp.1552-1556, 1936.

R. Demaimay, K. Adjou, V. Beringue, S. Demart, C. Lasmezas et al., Late EPHE Banque de Monographies SVT treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals, J Virol, vol.71, pp.9685-9689, 1997.

R. Demaimay, B. Chesebro, and B. Caughey, Inhibition of formation of protease-resistant prion protein by Trypan Blue, Sirius Red and other Congo Red analogs, Arch Virol, pp.277-283, 2000.
DOI : 10.1007/978-3-7091-6308-5_26

A. Dickinson and J. Mackay, Genetical control of the incubation period in mice of the neurological disease, scrapie, Heredity, vol.19, issue.2, pp.279-288, 1964.
DOI : 10.1038/hdy.1964.31

A. Dickinson, V. Meikle, and H. Fraser, Identification of a gene which controls the incubation period of some strains of scrapie agent in mice, Journal of Comparative Pathology, vol.78, issue.3, pp.293-299, 1968.
DOI : 10.1016/0021-9975(68)90005-4

A. Dickinson and D. Taylor, Resistance of scrapie agent to decontamination, N Engl J Med, vol.299, pp.1413-1414, 1978.

K. Doh-ura, T. Iwaki, and B. Caughey, Lysosomotropic Agents and Cysteine Protease Inhibitors Inhibit Scrapie-Associated Prion Protein Accumulation, Journal of Virology, vol.74, issue.10, pp.4894-4897, 2000.
DOI : 10.1128/JVI.74.10.4894-4897.2000

J. Elsen, Y. Amigues, F. Schelcher, V. Ducrocq, O. Andreoletti et al., Genetic susceptibility and transmission factors in scrapie: detailed analysis of an epidemic in a closed flock of Romanov, Archives of Virology, vol.144, issue.3, pp.431-445, 1999.
DOI : 10.1007/s007050050516

M. Enari, E. Flechsig, and C. Weissmann, Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody, Proceedings of the National Academy of Sciences, vol.98, issue.16, pp.9295-9299, 2001.
DOI : 10.1073/pnas.151242598

G. Forloni, N. Angeretti, R. Chiesa, E. Monzani, M. Salmona et al., Neurotoxicity of a prion protein fragment, Nature, vol.362, issue.6420, pp.543-546, 1993.
DOI : 10.1038/362543a0

H. Fraser and A. Dickinson, Targeting of scrapie lesions and spread of agent via the retino-tectal projection, Brain Research, vol.346, issue.1, pp.32-41, 1985.
DOI : 10.1016/0006-8993(85)91091-1

R. Gabizon, G. Telling, Z. Meiner, M. Halimi, I. Kahana et al., Insoluble wild???type and protease???resistant mutant prion protein in brains of patients with inherited prion disease, Nature Medicine, vol.83, issue.4, pp.59-64, 1996.
DOI : 10.1038/nm0196-59

C. Gajdusek, Discussion on Kuru, Scrapie and the Experimental Kuru-Like Syndrome in Chimpanzees, Curr Top Microbiol Immunol, vol.40, pp.59-63, 1967.
DOI : 10.1007/978-3-642-46059-3_7

D. Gajdusek, C. Gibbs, and M. Alpers, Experimental Transmission of a Kuru-like Syndrome to Chimpanzees, Nature, vol.23, issue.5025, pp.794-796, 1966.
DOI : 10.1038/209794a0

D. Gajdusek, C. Gibbs, and J. , Alpers M: Transmission and passage of experimenal "kuru" to chimpanzees, Science, vol.155, pp.212-214, 1967.

S. Gauczynski, J. Peyrin, S. Haik, C. Leucht, C. Hundt et al., The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein, The EMBO Journal, vol.20, issue.21, pp.5863-5875, 2001.
DOI : 10.1093/emboj/20.21.5863

C. Gibbs, J. Gajdusek, D. Asher, D. Alpers, M. Beck et al., Creutzfeldt-Jakob Disease (Spongiform Encephalopathy): Transmission to the Chimpanzee, Science, vol.161, issue.3839, pp.388-389, 1968.
DOI : 10.1126/science.161.3839.388

L. Goldfarb, P. Brown, E. Mitrova, L. Cervenakova, L. Goldin et al., Creutzfeldt-Jacob disease associated with the PRNP codon 200LYS mutation: An analysis of 45 families, European Journal of Epidemiology, vol.83, issue.5, pp.477-486, 1991.
DOI : 10.1007/BF00143125

W. Goldmann, N. Hunter, J. Foster, J. Salbaum, K. Beyreuther et al., Two alleles of a neural protein gene linked to scrapie in sheep., Proceedings of the National Academy of Sciences, vol.87, issue.7, pp.2476-2480, 1990.
DOI : 10.1073/pnas.87.7.2476

W. Goldmann, N. Hunter, G. Smith, J. Foster, and J. Hope, PrP Genotype and Agent Effects in Scrapie: Change In Allelic Interaction With Different Isolates of Agent in Sheep, a Natural Host of Scrapie, Journal of General Virology, vol.75, issue.5, pp.75989-995, 1994.
DOI : 10.1099/0022-1317-75-5-989

E. Graner, A. Mercadante, S. Zanata, V. Martins, D. Jay et al., Laminin-induced PC-12 cell differentiation is inhibited following laser inactivation of cellular prion protein, FEBS Letters, vol.268, issue.3, pp.257-260, 2000.
DOI : 10.1016/S0014-5793(00)02070-6

N. Greenfield, Methods to Estimate the Conformation of Proteins and Polypeptides from Circular Dichroism Data, Analytical Biochemistry, vol.235, issue.1, pp.1-10, 1996.
DOI : 10.1006/abio.1996.0084

V. Grigoriev, K. Adjou, N. Sales, S. Simoneau, J. Deslys et al., Effects of the Polyene Antibiotic Derivative MS-8209 on the Astrocyte Lysosomal System of Scrapie-Infected Hamsters, Journal of Molecular Neuroscience, vol.18, issue.3, pp.271-281, 2002.
DOI : 10.1385/JMN:18:3:271

F. Heppner, C. Musahl, I. Arrighi, M. Klein, T. Rulicke et al., Prevention of Scrapie Pathogenesis by Transgenic Expression of Anti-Prion Protein Antibodies, Science, vol.294, issue.5540, pp.178-182, 2001.
DOI : 10.1126/science.1063093

A. Hill, S. Joiner, J. Linehan, M. Desbruslais, P. Lantos et al., Species-barrier-independent prion replication in apparently resistant species, Proceedings of the National Academy of Sciences, vol.97, issue.18, pp.10248-10253, 2000.
DOI : 10.1073/pnas.97.18.10248

D. Hilton, E. Fathers, P. Edwards, J. Ironside, and J. Zajicek, Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease, The Lancet, vol.352, issue.9129, pp.703-704, 1998.
DOI : 10.1016/S0140-6736(98)24035-9

M. Hornshaw, J. Mcdermott, J. Candy, and J. Lakey, Copper Binding to the N-Terminal Tandem Repeat Region of Mammalian and Avian Prion Protein: Structural Studies Using Synthetic Peptides, Biochemical and Biophysical Research Communications, vol.214, issue.3, pp.993-999, 1995.
DOI : 10.1006/bbrc.1995.2384

C. Hundt, J. Peyrin, S. Haik, S. Gauczynski, C. Leucht et al., Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor, The EMBO Journal, vol.20, issue.21, pp.5876-5886, 2001.
DOI : 10.1093/emboj/20.21.5876

S. Inoue, M. Tanaka, M. Horiuchi, N. Ishiguro, and M. Shinagawa, Characterization of the Bovine Prion Protein Gene: The Expression Requires Interaction between the Promoter and Intron., Journal of Veterinary Medical Science, vol.59, issue.3, pp.175-183, 1997.
DOI : 10.1292/jvms.59.175

G. Jackson, I. Murray, L. Hosszu, N. Gibbs, J. Waltho et al., Location and properties of metal-binding sites on the human prion protein, Proceedings of the National Academy of Sciences, vol.98, issue.15, pp.8531-8535, 2001.
DOI : 10.1073/pnas.151038498

G. Jackson, I. Murray, L. Hosszu, N. Gibbs, J. Waltho et al., Location and properties of metal-binding sites on the human prion protein, Proceedings of the National Academy of Sciences, vol.98, issue.15, pp.8531-8535, 2001.
DOI : 10.1073/pnas.151038498

W. Johnson and J. , Secondary Structure of Proteins Through Circular Dichroism Spectroscopy, Annual Review of Biophysics and Biophysical Chemistry, vol.17, issue.1, pp.145-166, 1988.
DOI : 10.1146/annurev.bb.17.060188.001045

K. Kaneko, L. Zulianello, M. Scott, C. Cooper, A. Wallace et al., Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation, Proceedings of the National Academy of Sciences, vol.94, issue.19, pp.10069-10074, 1997.
DOI : 10.1073/pnas.94.19.10069

R. Kimberlin and C. Walker, Evidence that the Transmission of One Source of Scrapie Agent to Hamsters Involves Separation of Agent Strains from a Mixture, Journal of General Virology, vol.39, issue.3, pp.487-496, 1978.
DOI : 10.1099/0022-1317-39-3-487

Y. Kobayashi, K. Hirata, H. Tanaka, and T. Yamada, Quinacrine administration to a patient with Creutzfeldt- Jakob disease who received a cadaveric dura mater graft--an EEG evaluation, Rinsho Shinkeigaku, vol.43, pp.403-408, 2003.

D. Kocisko, G. Baron, R. Rubenstein, J. Chen, S. Kuizon et al., New Inhibitors of Scrapie-Associated Prion Protein Formation in a Library of 2,000 Drugs and Natural Products, Journal of Virology, vol.77, issue.19, pp.10288-10294, 2003.
DOI : 10.1128/JVI.77.19.10288-10294.2003

C. Korth, B. May, F. Cohen, and S. Prusiner, Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease, Proceedings of the National Academy of Sciences, vol.98, issue.17, pp.9836-9841, 2001.
DOI : 10.1073/pnas.161274798

M. Kramer, H. Kratzin, B. Schmidt, A. Romer, O. Windl et al., Prion Protein Binds Copper within the Physiological Concentration Range, Journal of Biological Chemistry, vol.276, issue.20, pp.16711-16719, 2001.
DOI : 10.1074/jbc.M006554200

A. Ladogana, P. Casaccia, L. Ingrosso, M. Cibati, M. Salvatore et al., Sulphate polyanions prolong the incubation period of scrapie-infected hamsters, Journal of General Virology, vol.73, issue.3, pp.73661-665, 1992.
DOI : 10.1099/0022-1317-73-3-661

C. Lasmezas, J. Deslys, R. Demaimay, K. Adjou, F. Lamoury et al., BSE transmission to macaques, Nature, vol.381, issue.6585, pp.743-744, 1996.
DOI : 10.1038/381743a0

C. Lasmezas, J. Deslys, O. Robain, A. Jaegly, V. Beringue et al., Transmission of the BSE Agent to Mice in the Absence of Detectable Abnormal Prion Protein, Science, vol.275, issue.5298, pp.402-405, 1997.
DOI : 10.1126/science.275.5298.402

D. Lee, C. Stenland, R. Hartwell, E. Ford, K. Cai et al., Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein, Journal of Virological Methods, vol.84, issue.1, pp.77-89, 2000.
DOI : 10.1016/S0166-0934(99)00135-4

N. Mabbott, K. Brown, J. Manson, and M. Bruce, T-lymphocyte activation and the cellular form of the prion protein, Immunology, vol.92, issue.2, pp.161-165, 1997.
DOI : 10.1046/j.1365-2567.1997.00331.x

S. Mahal, E. Asante, M. Antoniou, and J. Collinge, Isolation and functional characterisation of the promoter region of the human prion protein gene, Gene, vol.268, issue.1-2, pp.105-114, 2001.
DOI : 10.1016/S0378-1119(01)00424-3

S. Mahal, E. Asante, M. Antoniou, and J. Collinge, Isolation and functional characterisation of the promoter region of the human prion protein gene, Gene, vol.268, issue.1-2, pp.105-114, 2001.
DOI : 10.1016/S0378-1119(01)00424-3

T. Maignien, C. Lasmezas, V. Beringue, D. Dormont, and J. Deslys, Pathogenesis of the oral route of infection of mice with scrapie and bovine spongiform encephalopathy agents, Journal of General Virology, vol.80, issue.11, pp.3035-3042, 1999.
DOI : 10.1099/0022-1317-80-11-3035

G. Mallucci, T. Campbell, A. Dickinson, J. Beck, M. Holt et al., Inherited prion disease with an alanine to valine mutation at codon 117 in the prion protein gene, Brain, vol.122, issue.10, pp.1221823-1837, 1999.
DOI : 10.1093/brain/122.10.1823

A. Mange, N. Nishida, O. Milhavet, H. Mcmahon, D. Casanova et al., Amphotericin B Inhibits the Generation of the Scrapie Isoform of the Prion Protein in Infected Cultures, Journal of Virology, vol.74, issue.7, pp.3135-3140, 2000.
DOI : 10.1128/JVI.74.7.3135-3140.2000

P. Markovits, C. Dautheville, D. Dormont, L. Dianoux, and R. Latarjet, In vitro propagation of the scrapie agent, Acta Neuropathologica, vol.165, issue.1-2, pp.75-80, 1983.
DOI : 10.1007/BF00685350

B. May, A. Fafarman, S. Hong, M. Rogers, L. Deady et al., Potent inhibition of scrapie prion replication in cultured cells by bis-acridines, Proceedings of the National Academy of Sciences, vol.100, issue.6, pp.3416-3421, 2003.
DOI : 10.1073/pnas.2627988100

D. Merz, A. Scheid, and P. Choppin, Immunological studies of the functions of paramyxovirus glycoproteins, Virology, vol.109, issue.1, pp.94-105, 1981.
DOI : 10.1016/0042-6822(81)90474-8

O. Milhavet and S. Lehmann, Oxidative stress and the prion protein in transmissible spongiform encephalopathies, Brain Research Reviews, vol.38, issue.3, pp.328-339, 2002.
DOI : 10.1016/S0165-0173(01)00150-3

O. Milhavet, A. Mange, D. Casanova, and S. Lehmann, Effect of Congo Red on Wild-Type and Mutated Prion Proteins in Cultured Cells, Journal of Neurochemistry, vol.93, issue.1, pp.222-230, 2000.
DOI : 10.1046/j.1471-4159.2000.0740222.x

W. Muller, J. Laplanche, H. Ushijima, and H. Schroder, Novel approaches in diagnosis and therapy of Creutzfeldt???Jakob disease, Mechanisms of Ageing and Development, vol.116, issue.2-3, pp.193-218, 2000.
DOI : 10.1016/S0047-6374(00)00112-3

G. Murdoch, T. Sklaviadis, and E. Manuelidis, Manuelidis L: Potential retroviral RNAs in Creutzfeldt- Jakob disease, J Virol, vol.64, pp.1477-1486, 1990.

N. Nishida, D. Harris, D. Vilette, H. Laude, Y. Frobert et al., Successful Transmission of Three Mouse-Adapted Scrapie Strains to Murine Neuroblastoma Cell Lines Overexpressing Wild-Type Mouse Prion Protein, Journal of Virology, vol.74, issue.1, pp.320-325, 2000.
DOI : 10.1128/JVI.74.1.320-325.2000

M. Otto, M. Beekes, J. Wiltfang, E. Bahn, S. Poser et al., Elevated levels of serum SlOO beta protein in scrapie hamsters, Journal of Neurovirology, vol.4, issue.5, pp.572-573, 1998.
DOI : 10.3109/13550289809113503

P. Parchi, S. Capellari, S. Chen, R. Petersen, P. Gambetti et al., Typing prion isoforms, Nature, vol.386, issue.6622, pp.232-234, 1997.
DOI : 10.1038/386232a0

P. Parchi, A. Giese, S. Capellari, P. Brown, W. Schulz-schaeffer et al., Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects, Annals of Neurology, vol.19, issue.2, pp.224-233, 1999.
DOI : 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W

K. Peoc-'h, P. Manivet, P. Beaudry, F. Attane, G. Besson et al., Identification of three novel mutations (E196K, V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt-Jakob disease phenotype, Human Mutation, vol.15, issue.5, p.482, 2000.
DOI : 10.1002/(SICI)1098-1004(200005)15:5<482::AID-HUMU16>3.0.CO;2-1

D. Peretz, R. Williamson, K. Kaneko, J. Vergara, E. Leclerc et al., Antibodies inhibit prion propagation and clear cell cultures of prion infectivity, Nature, vol.9, issue.6848, pp.739-743, 2001.
DOI : 10.1038/35089090

V. Perrier, K. Kaneko, J. Safar, J. Vergara, P. Tremblay et al., Dominant-negative inhibition of prion replication in transgenic mice, Proceedings of the National Academy of Sciences, vol.99, issue.20, pp.13079-13084, 2002.
DOI : 10.1073/pnas.182425299

V. Perrier, A. Wallace, K. Kaneko, J. Safar, S. Prusiner et al., Mimicking dominant negative inhibition of prion replication through structure-based drug design, Proceedings of the National Academy of Sciences, vol.97, issue.11, pp.6073-6078, 2000.
DOI : 10.1073/pnas.97.11.6073

S. Priola, A. Raines, and W. Caughey, Porphyrin and Phthalocyanine Antiscrapie Compounds, Science, vol.287, issue.5457, pp.1503-1506, 2000.
DOI : 10.1126/science.287.5457.1503

S. Prusiner, Novel proteinaceous infectious particles cause scrapie, Science, vol.216, issue.4542, pp.136-144, 1982.
DOI : 10.1126/science.6801762

S. Prusiner, M. Mckinley, D. Groth, K. Bowman, N. Mock et al., Scrapie agent contains a hydrophobic protein., Proceedings of the National Academy of Sciences, vol.78, issue.11, pp.6675-6679, 1981.
DOI : 10.1073/pnas.78.11.6675

R. Race and B. Chesebro, Scrapie infectivity found in resistant species, Nature, vol.392, issue.6678, p.770, 1998.
DOI : 10.1038/33834

R. Race, L. Fadness, and B. Chesebro, Characterization of Scrapie Infection in Mouse Neuroblastoma Cells, Journal of General Virology, vol.68, issue.5, pp.1391-1399, 1987.
DOI : 10.1099/0022-1317-68-5-1391

W. Rachidi, D. Vilette, P. Guiraud, M. Arlotto, J. Riondel et al., Expression of Prion Protein Increases Cellular Copper Binding and Antioxidant Enzyme Activities but Not Copper Delivery, Journal of Biological Chemistry, vol.278, issue.11, pp.9064-9072, 2003.
DOI : 10.1074/jbc.M211830200

C. Reilly, Beta-sheet breaker peptides reverse conformation of pathogenic prion proteins, J Neurol, vol.247, pp.319-320, 2000.

E. Richardson, J. Masters, and C. , in the Nervous System, Brain Pathology, vol.409, issue.1, pp.33-41, 1995.
DOI : 10.1038/370295a0

R. Rieger, F. Edenhofer, C. Lasmezas, and S. Weiss, The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells, Nature Medicine, vol.75, issue.12, pp.1383-1388, 1997.
DOI : 10.1038/nm1297-1383

R. Riek, S. Hornemann, G. Wider, M. Billeter, R. Glockshuber et al., NMR structure of the mouse prion protein domain PrP(121???231), Nature, vol.382, issue.6587, pp.180-182, 1996.
DOI : 10.1038/382180a0

H. Rudyk, S. Vasiljevic, R. Hennion, C. Birkett, J. Hope et al., Screening Congo Red and its analogues for their ability to prevent the formation of PrP-res in scrapie-infected cells, Journal of General Virology, vol.81, issue.4, pp.1155-1164, 2000.
DOI : 10.1099/0022-1317-81-4-1155

G. Saborio, B. Permanne, and C. Soto, Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding, Nature, vol.411, issue.6839, pp.810-813, 2001.
DOI : 10.1038/35081095

K. Saeki, Y. Matsumoto, and T. Onodera, Identification of a Promoter Region in the Rat Prion Protein Gene, Biochemical and Biophysical Research Communications, vol.219, issue.1
DOI : 10.1006/bbrc.1996.0179

H. Schagger and G. Von-jagow, Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa, Analytical Biochemistry, vol.166, issue.2, pp.368-379, 1987.
DOI : 10.1016/0003-2697(87)90587-2

M. Schmerr, A. Jenny, M. Bulgin, J. Miller, A. Hamir et al., Use of capillary electrophoresis and fluorescent labeled peptides to detect the abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathy, Journal of Chromatography A, vol.853, issue.1-2, pp.207-214, 1999.
DOI : 10.1016/S0021-9673(99)00514-2

B. Schreuder, L. Van-keulen, M. Vromans, J. Langeveld, and M. Smits, Preclinical test for prion diseases, Biomedicine & Pharmacotherapy, vol.51, issue.3, p.563, 1996.
DOI : 10.1016/S0753-3322(97)86912-0

M. Scott, J. Safar, G. Telling, O. Nguyen, D. Groth et al., Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice, Proceedings of the National Academy of Sciences, vol.94, issue.26, pp.14279-14284, 1997.
DOI : 10.1073/pnas.94.26.14279

Y. Shaked, H. Rosenmann, N. Hijazi, M. Halimi, and R. Gabizon, Copper Binding to the PrP Isoforms: a Putative Marker of Their Conformation and Function, Journal of Virology, vol.75, issue.17, pp.7872-7874, 2001.
DOI : 10.1128/JVI.75.17.7872-7874.2001

S. Shibuya, J. Higuchi, R. Shin, J. Tateishi, and T. Kitamoto, Codon 219 lys allele of PRNP is not found in sporadic Creutzfeldt-Jakob disease, Annals of Neurology, vol.94, issue.6, pp.826-828, 1998.
DOI : 10.1002/ana.410430618

C. Soto, Alzheimer's and prion disease as disorders of protein conformation: implications for the design of novel therapeutic approaches, Journal of Molecular Medicine, vol.77, issue.5, pp.412-418, 1999.
DOI : 10.1007/s001090050371

C. Soto, L. Anderes, S. Suardi, F. Cardone, J. Castilla et al., Pre-symptomatic detection of prions by cyclic amplification of protein misfolding, FEBS Letters, vol.92, issue.3, pp.638-642, 2005.
DOI : 10.1016/j.febslet.2004.12.035

N. Stahl, D. Borchelt, K. Hsiao, and S. Prusiner, Scrapie prion protein contains a phosphatidylinositol glycolipid, Cell, vol.51, issue.2, pp.229-240, 1987.
DOI : 10.1016/0092-8674(87)90150-4

N. Stahl, D. Borchelt, and S. Prusiner, Differential release of cellular and scrapie prion proteins from cellular membranes by phosphatidylinositol-specific phospholipase C, Biochemistry, vol.29, issue.22, pp.5405-5412, 1990.
DOI : 10.1021/bi00474a028

C. Stenland, D. Lee, P. Brown, S. Petteway, and J. , Partitioning of human and sheep forms of the pathogenic prion protein during the purification of therapeutic proteins from human plasma, Transfusion, vol.233, issue.11, pp.1497-1500, 2002.
DOI : 10.1046/j.1423-0410.2000.7820086.x

S. Supattapone, H. Nguyen, F. Cohen, S. Prusiner, and M. Scott, Elimination of prions by branched polyamines and implications for therapeutics, Proceedings of the National Academy of Sciences, vol.96, issue.25, pp.14529-14534, 1999.
DOI : 10.1073/pnas.96.25.14529

J. Tatzelt, D. Groth, M. Torchia, S. Prusiner, and S. Dearmond, Kinetics of Prion Protein Accumulation in the CNS of Mice with Experimental Scrapie, Journal of Neuropathology & Experimental Neurology, vol.58, issue.12, pp.1244-1249, 1999.
DOI : 10.1097/00005072-199912000-00005

I. Tobler, S. Gaus, T. Deboer, P. Achermann, M. Fischer et al., Altered circadian activity rhythms and sleep in mice devoid of prion protein, Nature, vol.380, issue.6575, pp.639-642, 1996.
DOI : 10.1038/380639a0

E. Turk, D. Teplow, L. Hood, and S. Prusiner, Purification and properties of the cellular and scrapie hamster prion proteins, European Journal of Biochemistry, vol.172, issue.1, pp.21-30, 1988.
DOI : 10.1146/annurev.bi.50.070181.004031

M. Vey, S. Pilkuhn, H. Wille, R. Nixon, S. Dearmond et al., Subcellular colocalization of the cellular and scrapie prion proteins in caveolae-like membranous domains, Proceedings of the National Academy of Sciences, vol.93, issue.25, pp.14945-14949, 1996.
DOI : 10.1073/pnas.93.25.14945

J. Viles, F. Cohen, S. Prusiner, D. Goodin, P. Wright et al., Copper binding to the prion protein: Structural implications of four identical cooperative binding sites, Proceedings of the National Academy of Sciences, vol.96, issue.5, pp.2042-2047, 1999.
DOI : 10.1073/pnas.96.5.2042

D. Vilette, O. Andreoletti, F. Archer, M. Madelaine, J. Vilotte et al., Ex vivo propagation of infectious sheep scrapie agent in heterologous epithelial cells expressing ovine prion protein, Proceedings of the National Academy of Sciences, vol.98, issue.7, pp.4055-4059, 2001.
DOI : 10.1073/pnas.061337998

M. Vogtherr, S. Grimme, B. Elshorst, D. Jacobs, K. Fiebig et al., Antimalarial Drug Quinacrine Binds to C-Terminal Helix of Cellular Prion Protein, Journal of Medicinal Chemistry, vol.46, issue.17, pp.3563-3564, 2003.
DOI : 10.1021/jm034093h

C. Wegner, A. Romer, R. Schmalzbauer, H. Lorenz, O. Windl et al., Mutant prion protein acquires resistance to protease in mouse neuroblastoma cells, Journal of General Virology, vol.83, issue.5, pp.1237-1245, 2002.
DOI : 10.1099/0022-1317-83-5-1237

D. Westaway, C. Cooper, S. Turner, D. Costa, M. Carlson et al., Structure and polymorphism of the mouse prion protein gene., Proceedings of the National Academy of Sciences, vol.91, issue.14, pp.6418-6422, 1994.
DOI : 10.1073/pnas.91.14.6418

A. White and S. Hawke, Immunotherapy as a therapeutic treatment for neurodegenerative disorders, Journal of Neurochemistry, vol.23, issue.4, pp.801-808, 2003.
DOI : 10.1046/j.1471-4159.2003.02064.x

R. Will, J. Ironside, M. Zeidler, S. Cousens, K. Estibeiro et al., A new variant of Creutzfeldt-Jakob disease in the UK. Lancet, pp.921-925, 1996.

R. Will, M. Zeidler, G. Stewart, M. Macleod, J. Ironside et al., Diagnosis of new variant Creutzfeldt-Jakob disease, Annals of Neurology, vol.15, issue.5, pp.575-582, 2000.
DOI : 10.1002/1531-8249(200005)47:5<575::AID-ANA4>3.0.CO;2-W

H. Wille, M. Michelitsch, V. Guenebaut, S. Supattapone, A. Serban et al., Structural studies of the scrapie prion protein by electron crystallography, Proceedings of the National Academy of Sciences, vol.99, issue.6, pp.3563-3568, 2002.
DOI : 10.1073/pnas.052703499

K. Winklhofer, F. Hartl, and J. Tatzelt, and the screening of anti-prion compounds, FEBS Letters, vol.389, issue.1, pp.41-45, 2001.
DOI : 10.1016/S0014-5793(01)02692-8

R. Zahn, A. Liu, T. Luhrs, R. Riek, V. Schroetter et al., NMR solution structure of the human prion protein, Proceedings of the National Academy of Sciences, vol.97, issue.1, pp.145-150, 2000.
DOI : 10.1073/pnas.97.1.145

M. Zeidler, G. Stewart, C. Barraclough, D. Bateman, D. Bates et al., New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests, The Lancet, vol.350, issue.9082, pp.903-907, 1997.
DOI : 10.1016/S0140-6736(97)07472-2